Post by Fayaz Shah

A world-class molecule cannot fix a broken commercial system. On average, post-pandemic launch trajectories are underperforming and declining. Why? Because we get caught in a dangerous mental trap: we assume that if the clinical science is proven, the market will naturally open its doors. To succeed in the modern life sciences landscape, we must shift our executive mindset from "Product Promoters" to "Systemic Commercial Architects". Launch excellence isn’t about who has the loudest marketing budget; it is about how well you integrate your clinical data with on-the-ground operational realities. #Pharma #LaunchExcellence #CommercialExcellence #MedicalAffairs #MarketAccess #Leadership #LifeSciences #Biotech